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ATP synthase: from single molecule to human bioenergetics
By Yasuo KAGAWA*1,*2,†
(Communicated by Fumio OOSAWA, M.J.A.)
Abstract: ATP synthase (FoF1) consists of an ATP-driven motor (F1)a n daH +-driven
motor (Fo), which rotate in opposite directions. FoF1 reconstituted into a lipid membrane is capable
of ATP synthesis driven by H+ ﬂux. As the basic structures of F1 (,3-3./C) and Fo (ab2c10) are
ubiquitous, stable thermophilic FoF1 (TFoF1) has been used to elucidate molecular mechanisms,
while human F1Fo (HF1Fo) has been used to study biomedical signiﬁcance. Among F1s, only
thermophilic F1 (TF1) can be analyzed simultaneously by reconstitution, crystallography,
mutagenesis and nanotechnology for torque-driven ATP synthesis using elastic coupling
mechanisms. In contrast to the single operon of TFoF1,H F oF1 is encoded by both nuclear DNA
with introns and mitochondrial DNA. The regulatory mechanism, tissue speciﬁcity and
physiopathology of HFoF1 were elucidated by proteomics, RNA interference, cytoplasts and
transgenic mice. The ATP synthesized daily by HFoF1 is in the order of tens of kilograms, and is
primarily controlled by the brain in response to ﬂuctuations in activity.
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Introduction
All human activity depends on ATP, which is
primarily synthesized via mitochondrial oxidative
phosphorylation (oxphos). By analogy with glyco-
lytic ATP synthesis, there have been many futile
attempts to isolate hypothetical high-energy inter-
mediates, such as phosphoenolpyruvate, that tightly
couple respiratory energy to ATP synthesis. In 1961,
Mitchell proposed the chemiosmotic hypothesis,
which states that in oxphos, the respiratory energy
is coupled to an imaginary anisotropic “ATPase
system” located in an ion-impermeable membrane
(Fig. 1 of Ref. 1) via H+/OH− ﬂux driven by the
electrochemical activity ([H+]Left/[H+]Right =1 0 7 ×
[ATP]/[ADP]) across the membrane.1) At the same
time, soluble ATPase, known as coupling factor 1
(F1), was puriﬁed from mitochondria in Racker’s
laboratory.2) When F1 was bound to F1-deﬁcient
mitochondrial membrane, respiratory energy was
coupled to ATP synthesis.2) The author then isolated
the entire ATP synthase, later called FoF1 (Fig. 1,
right), and reconstituted FoF1 into liposomes capable
of converting energy from ATP hydrolysis to that
for H+ ﬂux driven by the electrochemical potential
of protons across the membrane ("7H+), where
"7H+ =F "A − 2.3RT"pH.3) The H+ ﬂux through
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©2010 The Japan AcademyFoF1 liposomes was demonstrated ﬁrst by a pH meter
(Fig. 6 of Ref. 3). After the primary chemiosmotic
hypothesis1) was thus partially established,3) the
subunit-subunit interactions in FoF1 during ATP
synthesis became the next research target. Boyer
proposed a hypothetical two-subunit model of con-
formational energy transfer, and ﬁnally proposed the
rotational hypothesis in 1981,4) based on our report
on thermophilic F1 (TF1) subunits with ubiquitous
stoichiometry ,3-3./C (Fig. 1, upper left)5) and
conformational changes of isolated TF1- from -E
(with an empty catalytic site) to -D or -T by binding
ADP or ATP, respectively.6),7)
The objectives of this review are to publish how
achievements on thermophilic FoF1 (TFoF1) in Japan
have advanced the primary chemiosmotic1) and
rotational4) theories, and how our studies on human
FoF1 (HFoF1) will contribute to the development of
human bioenergetics. To date, ligand-binding , or -
subunits have only been isolated and reconstituted
into ,- subcomplexes from TF1.5)–7) In contrast to
active ,3-3 hexamer and ,1-1 dimer of TF1,7)
attempts to reconstitute ,- subcomplexes from E.
coli F1 (EF1) and HF1 in vitro has been unsuccess-
ful. However, functional complementation of yeast
F1 (YF1) in a quintuple deletion mutant
(","-"."/"C) with genes encoding ,, -, . and C
of BF1 strongly suggests the presence of common
structure and function of HF1 subunits.8) Thus, the
molecular mechanisms by which rotation and catal-
ysis are coupled were mainly elucidated by crucial
experiments using TF1 and TFo (ab2c10) to represent
all FoF1s.7) The rotational hypothesis4) assumes that
on ATP synthesis, the eccentric central stalk (.C)
connected to the c10 ring is rotated against the ,3-3
hexamer in the clockwise direction, as viewed from
the Fo side (Fig. 1, right). This rotation induces
cyclic conformational changes of - in the order of
-E→-D→-T→-E so as to change the aﬃnity for
nucleotides, and ﬁnally release ATP to return to -E
(Fig. 1, middle and upper right).4),7) In fact, Walker’s
X-ray crystallography of most of ,3-3. of BF1
visualized the distinct conformations of - with
diﬀerent nucleotide occupancies (-E, -D and -T).9)
The concept of FoF1 as an H+-driven rotor (.-
c10) and stator (/-ab2), rotating with a torque of
42pNnm, was predicted in 1996 (Fig. 1, right).10)
The most convincing evidence of the rotational
hypothesis was the direct observation of the rotation
of an actin ﬁlament attached to . against the ﬁxed
,3-3 hexamer by Noji11) in 1997, using the TF1
gene.12) Brieﬂy, the ATP-driven F1 motor rotates
clockwise (Fig. 1, upper left) and the H+-driven Fo
motor rotates in the anticlockwise direction as viewed
from the F1 side (Fig. 1, lower left).7),10),11) Prelimi-
nary experiments on “the 120° rotation of the c
subunit oligomer” have been reported,13) but this was
not sensitive to Fo inhibitor and may represent the .
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Fig. 1. Basic structure of TF1 (ATP-driven motor), TFo (proton-driven motor) and TFoF1 (proton-driven ATP synthase). Upper left:
Side view of TF1 composed of ,, -, ., /, and C subunits. The .C turns counterclockwise against the ,3-3 hexamer in the ATP
hydrolysis direction when viewed from the Fo side. Middle: Top view of TF1 with three diﬀerent conformations of - subunits. Lower
left: Side view of TFo composed of a, b and c subunits. The c10 ring turns clockwise against ab2 in the proton-driven direction. Right:
Side view of TFoF1. The central stalk (.C) turns with the c10 rotor clockwise in the ATP synthesis direction when viewed from TFo
side.
Y. KAGAWA [Vol. 86, 668rotation in the F1 portion of FoF1. In fact, crystallo-
graphic analysis of yeast FoF1 (YFoF1) revealed that
the ring of c subunits contains 10 protomers, rather
than the widely anticipated 12 (4H+ per 120°
rotation), and tightly connected to ./C complex.14)
Although crystal of EFo is not available, exact experi-
ments on TFoF1 conﬁrmed the c10-ring structure
(Fig. 1, right).15) By using single-molecule FRET
measuring the change in the distance between the
subunits a and c during the rotation (see section 6.1),
a 36° sequential stepping mode of the c10-ring
rotation in FoF1 was conﬁrmed.16) ATP is synthe-
sized at the clefts between , and - by "7H+-driven
H+ ﬂux when both motors are connected by central
(.C) and peripheral stalks (ab2/) to the c10-ring in
TF1 (Fig. 1).7),14),17) Elucidation of primary struc-
tures of E. coli FoF1 (EFoF1)18) and TFoF1,12),19) and
site-directed mutagenesis18),20) and suppression of the
lost functions18) led to reﬁnements in the rotational
hypothesis including elastic power transmission.10)
After the primary rotational hypothesis4) was
thus partially established,7),10),11),17) research on FoF1
was divided into single molecular elucidation of
energy transduction at the atomic level using stable
TFoF1
12),17),20) and biomedical elucidation of human
FoF1 (HFoF1)21) at the mitochondrial22) and in vivo
levels.23) In contrast to the single operon of bacterial
FoF1,12),18),19) animal FoF1 is encoded by both nuclear
DNA21),24),25) and mitochondrial DNA.22),26) The
primary structures of bovine FoF1 (BFoF1)24),25) and
HFoF1
21),27),28) were sequenced, and cDNAs of the -
subunits of BF1 and HF1, for example, were found to
share 99% amino acid homology and 94% nucleotide
homology (authors report in 1986 quoted in Ref. 21).
Although the core structure of TFoF1 (,3-3./C +
ab2c10)7),10),12) (Fig. 1) was conserved in H(B)FoF1,i t
is more complex due to additional 8 subunits (d, e,
f, g, A6L (ATP8), OSCP and F6, plus a natural
inhibitor called IF1) (Fig. 2)21),24),25); subunits / and C
of TF1 correspond to OSCP (oligomycin sensitivity
conferring protein) and the /C complex in HF1,
respectively.21) Although mammalian / subunit is
partially homologous to C subunit of TF1, X-ray
crystallographic data of both BF1
29) and YF1
14)
showed that /C complex interacts with a Rossmann
fold in the . subunit, forming a foot and c10-.-/-C
rotates as an ensemble central stalk (Fig. 2),14),29)
similar to the C subunit at the . subunit in TF1
(Fig. 1).7),17) In fact, the /C complex was dissociated
from BF1 by guanidine treatment as a stable
heterodimer (Papageorgiou, S., and Solaini, G.,
2004, PubMed abstract). So called minor subunits
(e, f, g and A6L) of HFo are unlikely to have a role
directly in ATP synthesis, but they appear to
inﬂuence oligomeric state of HFoF1.21),25) Supra-
molecular structures of HFoF1 include HFoF1 dimer30)
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Fig. 2. Side view of space ﬁlling model of HFoF1. As there is high homology among FoF1s from diﬀerent species,12),17)–21) and quintuple
yeast deletion YF1 mutant (","-"."/"C) is complemented by genes encoding BF1,8) the major structure of eukaryotic FoF1 is
apparently universal.9),14),25),29),73)–76) Thus, X-ray crystallography data for FoF1 subunits from diﬀerent species were taken from
RCSB Protein Data Bank (http://www.rcsb.org/pdb/results/results.do?outformat) and assembled according to sequence data for
HFoF1.21) No high-resolution structural data are available for subunit a and the hinge region of subunit b. ATP synthasome contains
both PIC and ANC.31) PIC: Phosphate carrier; ANC: Adenine nucleotide carrier.
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carrier (PIC), adenine nucleotide carrier (ANC) and
HFoF1 (Fig. 2). Moreover, there are tissue diﬀerences
in HFoF1, with muscle- and liver-type . subunits in
HF1.27) The complex gene structure,21),28) speciﬁc
regulation systems,21),28) expression and alternative
splicing27),32) of HFoF1 and related regulatory genes
were elucidated by recent cytoplast technology,22),33)
transgenic mice,32) transcriptomics21),32) and proteo-
mics.31),32) Based on the knowledge from these
extensive studies,7),17),21) human energetics in phys-
iological activities21) and diseases21),23) have been
analyzed.
In this article, mechanistic studies of FoF1,
including a reconstitution study and crystallography,
will be reviewed, and then, more complex mitochon-
drial cytobiology and human biomedical studies will
be described, because mitochondrial structure, neuro-
hormonal control, tissue-speciﬁc activity and disease
are not found in bacteria. Historical evaluations of
contributions made by scientists in mechanistic
studies are summarized in excellent reviews (Refs. 4
and 17, and references therein).
1. Isolation of ATP synthase (FoF1)b y
membrane biology
FoF1 is a membrane protein of oxidative
phosphorylation. In the 1960s, membrane biology
was in its infancy, and the many attempts to
purify ATP-synthesizing membrane proteins from
mitochondria had been unsuccessful. Long before
Fleischer’s group extracted phospholipids from the
mitochondrial membrane with aqueous-acetone (10%
water) and restored electron transport activity by
adding back phospholipid micelles in 1962,34)
Kakiuchi succeeded in a similar experiment in
1926.35) Okunuki36) succeeded in preparing several
cytochromes. Green’s group prepared electron trans-
port components from mitochondria.37) However,
even after phospholipids were added back and
electron transport activity was restored,34)–37) lip-
osomes capable of "7H+-driven oxphos, as predicted
by Mitchell,1) were not reconstituted.
Membrane proteins were classiﬁed into extrinsic
and intrinsic proteins.3) Extrinsic proteins, such as
cytochrome c36) and F1,2),5) or components of F1,
including OSCP3),25) and F6
3),25) (Figs. 1 and 2), are
easily detached from the biomembrane by treatment
with ultrasonic irradiation, chelating agents, and
chaotropic anions (KI, KCN),3) and can be puriﬁed as
soluble proteins in the water phase by chromatog-
raphy and ammonium sulfate fractionation. How-
ever, intrinsic proteins including cytochrome oxi-
dase36),37) and Fo
3) are hydrophobic and embedded in
the lipid bilayer, and require proper detergents for
solubilization3) (Fig. 3, right). In 1966, detailed phase
diagrams of phospholipid cholate system were
reported,38) and these were useful for solubilizing
intrinsic proteins and reconstituting functional bio-
membrane.3),39),40) The detergent concentration
needed to solubilize FoF1 is near its critical micelle
concentration.3)
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Fig. 3. Reconstitution of FoF1 from subunits and FoF1 liposomes from phospholipids.3),39) Isolated nucleotide-binding , and -
subunits6),56) and ,3-3 hexamer were obtained by dissociation of TF1 (upper left). Solubilized Fo or FoF1 was mixed with
phospholipids and cholate, and dialyzed to reconstitute FoF1 liposomes (bottom right, electron micrograph) capable of proton-driven
ATP synthesis.
Y. KAGAWA [Vol. 86, 670The F1 reported by Racker’s laboratory2) was
not sensitive to an energy transfer inhibitor of
oxphos, oligomycin, but became oligomycin sensitive
when bound to F1-depleted mitochondrial mem-
brane.41) The oligomycin sensitivity conferring factor
(Fo,H +-driven motor, Fig. 1) was characterized as an
intrinsic membrane protein,41) and by using cholate,
oligomycin-sensitive ATPase, later designated FoF1,
was isolated (Fig. 3).3),42) FoF1 was reconstituted
from Fo and F1.42) The electron microscopic images of
BFoF1 revealed spherical 3H-acetyl-BF1 attached to
membrane-embedded BFo.43) In combined morpho-
logical-biochemical studies to identify the in situ
structure of BFoF1,43) radiolabeled BF1 was added to
BFo membrane, and then the structure, radioactivity
and ATPase activity were removed in parallel.43)
However, mitochondrial F1s, including BF1 and
HF1, are unstable and reconstitution of F1 from each
isolated subunit was unsuccessful, even with chaper-
ones. Thus, TF1
7),44) and TFoF1
7),45) were puriﬁed
from thermophilic bacillus PS3, and stable TFoF1
was reconstituted from TF1 and TFo (Fig. 1).7),44),45)
Recent proteomics using mild detergent extraction of
HFoF1 from membrane followed by native gel electro-
phoresis revealed supramolecular structures includ-
ing dimeric HFoF1
30) and ATP synthasome (PIC +
ANC)31) (Fig. 2) (see section 9).
2. Reconstitution of FoF1 membrane capable of
ATP synthesis by proton ﬂux
FoF1 converts energy of "7H+ driven H+
ﬂux into ATP synthesis. Incorporation of
membrane proteins into the lipid bilayer is essential
in activity studies in membrane biology. The most
diﬃcult step was the reconstitution of liposomes
containing active membrane proteins capable of
producing "7H+.3),39),40) The use of removable
detergents, including cholate, was essential in the
preparation of BFoF1 (Fig. 3),3),39),40) and after
cholate extraction, Triton-X100 was used in the
chromatography to purify TFoF1.45) The removal of
14C-cholate during dialysis was estimated by radio-
activity,3),40) and tight closure of the liposome
membrane was estimated by radioactivity of enclosed
14C-inulin and conﬁrmed by electron microscopy of
enclosed ferritin.3),40) Electron microscopy showed
liposomal membranes studded with closely neighbor-
ing F1 (Fig. 3, lower right).3),43) As several extrinsic
proteins in oxphos, including F1, OSCP and F6 were
partially lost during the extraction and dialysis of
FoF1, the best activity was attained by adding these
after dialysis.3),39)
These liposomes showed H+ translocation on
addition of ATP,3),40),46) ATP-32Pi exchange reac-
tions3),39),46) or H+-driven ATP synthesis (Fig. 1,
right).46) Thus, FoF1-liposome was shown to be the
anisotropic “ATPase system” imagined by Mitchell.1)
ATP synthesis was sensitive to the combination of
valinomycin (K+ ionophore) and nigericin (H+–K+
exchange ionophore), which collapsed "7H+.3),39),46)
More stable TFoF1-liposomes synthesized ATP
from ADP and Pi with energy from proton ﬂux
driven by "7H+ formed by "pH and "A across their
membranes.46) Using chloroplasts, ATP synthesis
from ADP and Pi was demonstrated by applying
"pH using acid–base transition47) and by imposing
"A using an electric pulse.48) However, chloroplasts
contain an electron transport system and other
components that are energized by either "pH or
"A. Thus, net ATP synthesis by applying "pH
(acid–base transition) or "A (external electric pulse)
to puriﬁed TFoF1 reconstituted in liposome46) was the
most convincing evidence of chemiosmotic theory.1)
The electrical potential between the inside and
outside of liposomes formed by K+ diﬀusion in the
presence of valinomycin was calculated as "A =R T /
F × ln([K+]out/[K+]in). Maximal net ATP synthesis
from ADP and Pi was achieved by incubating vesicles
in malonate at pH 5.5 with valinomycin, and then
rapidly transferring them to a solution of pH 8.4 and
150mM K+.7),46) To synthesize ATP, the minimal
"7H+ (= "A − 60"pH, at 30°C) of 210mV and
optimal "7H+ of 290mV was required.46) The H+-
conducting activity of TFo-liposome through TFo
was proportional to the imposed "7H+ (6H+/sec/
103mV at pH 8.0).49) The pH proﬁle of the rate
revealed that a proton, not a hydroxyl ion, was the
true substrate.49) Because of the kinetic equivalency
between "* and "pH as driving forces of ATP
synthesis,46) "A is expected to replace "7H+. In fact,
TFoF1-liposomes irradiated with external electric
pulses (760V/cm, 30ms, rectangular) catalyzed net
ATP synthesis.50) The amount of ATP synthesized
increased with the number, voltage and duration of
electric pulses.50) The net synthesis of ATP by
application of "7H+ across the TFoF1-lipo-
somes46),50) ﬁrmly established the chemiosmotic
hypothesis.1) To directly measure "* with electrodes
on both sides of the membrane, TFoF1 was recon-
stituted into planar phospholipid bilayers, and the
magnitude of the electric current generated upon
addition of ATP was shown to follow simple
Michaelis–Menten type kinetics, and the Km was
found to be 0.14mM.51) There was no apparent
ATP synthase: from single molecule to human bioenergetics No. 7] 671dependence of Km on "*.51) This observation
indicates that "7H+ does not directly aﬀect Km to
release the ATP formed on TFoF1,7),51) and opens the
way for conformational energy transfer in ATP
synthesis.
Since the success of the FoF1-liposome,3),39),46)
the reconstitution method has been used to analyze
the activity of intrinsic proteins including channels,
receptors and membrane proteins. Using the lip-
osome method, the important outer membrane
diﬀusion channel known as VDAC, (voltage-depend-
ent anion channel) in mitochondrial transport was
isolated in 1980 (see sections 9 and 10).52)
3. Reconstitution of F1 subunit complexes
capable of ATP synthesis by torque
3.1. Core components of Fo are a, b, and c
subunits and those of F1 are ,, -, ., / and C.
The structure of FoF1 is shown in Figs. 1
and 2.7),9),12),18),53),54) Complete reconstitution of F1
(370kDa), after complete denaturation of all sub-
units into their primary structures with sodium
dodecylsulfate and urea and refolding into tertiary
structure,53) from subunits , (55kDa), - (52kDa), .
(32kDa), / (20kDa) and C (14kDa) was possible only
in TF1 (Fig. 3).53) The intermediate core subunit
complexes, ,1-1 dimer55) and ,3-3 hexamer,55) were
also only obtained in TF1, although the sequence
homologies of core subunits were conserved in
HF1 (371kDa).21) Enzymology revealed that ,3-3
hexamer was an oligomer, while ,1-1 dimer was a
protomer.55) Owing to the stability of TF1, the
subcomplexes with chemically modiﬁed and mutated
subunits were useful for nanotechnology.7),17),54)
TFo (148kDa) is composed of a (30kDa), b
(17kDa) and c (8kDa) in a stoichiometric ratio of
1:2:10 (Figs. 1 and 3).7),12),17) HFo and BFo contain,
in addition to the common subunits a (also called
ATP6; 25kDa), b (25kDa), and c (8kDa), minor
subunits d (19kDa), e (8kDa), f (10kDa), g (11
kDa), F6 (9kDa) and A6L (also called ATP8;
8kDa)18),25),29) (Fig. 2). The single stalk BFo obtained
by urea-cholate treatment of BFoF1 was reconsti-
tuted with externally added 3H-acetyl-F1 and the
additional peripheral stalk components OSCP and F6
were demonstrated in 1971.3),39),40) Isolated BFo
subunits other than OSCP and F6 are unstable, and
their reconstitution has been unsuccessful without
presequence and organizing machinery, even with
chaperones.21) These BFo subunits were only identi-
ﬁed on gel electrophoresis and X-ray crystallogra-
phy.25),29) FoF1 was seen as a sphere (,3-3 hexamer
portion, diameter 12nm× height 10nm)43) connected
by two stalks (central and peripheral) to a basal piece
(subunits a and c10 ring) (Fig. 3, lower right).3),43)
3.2. Protomeric, oligomeric and rotational
ATPases: ,1-1 dimer, ,3-3 hexamer and ,3-3.
heptamer. The isolated , and - subunits of TF1
both have AT(D)P-Mg binding activity accompanied
by conformational changes6) without ATPase activity
(Fig. 3, left).55),56) The open structure of -E and closed
structures of -D and -T in the presence of ligands were
conﬁrmed in the isolated thermophilic - using 1H-
NMR.56) Both thermophilic , and - subunits were
reconstituted to form an active ,1-1 dimer by forming
a catalytic ,- interface.55) Three ,1-1 dimers were
reconstituted to form an allosterically active ,3-3
hexamer (Fig. 3, upper middle).55) Both the high
catalytic activity and formation of F1-bound ATP
from ADP + Pi depend on the ,3-3. structure with
rotational ATPase.7),11),17) There are six potential
nucleotide-binding sites on F1 and ,3-3.: three
catalytic sites on - and three noncatalytic sites on
,,7),17) as conﬁrmed by X-ray crystallography.9)
Depending on the occupancy of catalytic sites
with increasing ATP concentration ([ATP]), there
are three types of ATPase activities of F1: uni-site,
bi-site and tri-site.4),57) Uni-site catalysis is measured
at sub-stoichiometric ATP concentrations ([ATP] <
[F1]). Uni-site activity is very low, and the apparent
KmATP is less than 20nM.57) The ATPase activity of
the ,1-1 dimer of TF1
57) showed typical Michaelis–
Menten kinetics with only one KmATP value of 70µM,
and a Vmax value of 0.1unit/mg, without the
cooperative characteristics of a protomer.57) In
contrast, ATPase activity of the ,3-3 hexamer
showed the cooperative characteristics of an oligo-
mer.58) The apparent KmATPs of oligomeric ATPase
of ,3-3 at 25°C were about 150µM (bi-site) and
490µM (tri-site).58) KmATPs of rotational ATPase of
TF1 (Fig. 3, right) were about 80µM (bi-site) and
490µM (tri-site).58) The .-containing complexes
,3-3., ,3-3./ and ,3-3.C, show common kinetic
properties.59) The ,3-3 hexamer was inhibited by
only one mole of [3H]-3′-O-(4-benzoyl) benzoyl-ADP
per hexamer, similarly to both BF1 and TF1.60) Thus,
the presence of only one inhibited-- in the hexamer
blocked multi-site steady-state ATPase activity.
This single-hit inactivation and cooperativity is an
inherent property of the symmetrical ,3-3, but is
not the due to the inhibition of rotation by TF1 or
,3-3..
3.3. Rotation of the . subunit in ,3-3
hexamer of TF1: One mole ATP hydrolysis at
Y. KAGAWA [Vol. 86, 672one - subunit drives 120° rotation of . subunit in
a concerted manner. The rotational hypothesis of
FoF1
4) was also proposed by Oosawa as the “loose
coupling mechanism of rotational proton ATPase”
based on analogy with the H+-driven ﬂagella motor
in 1986.61) The rotation of the . subunit axis in the
cylinder of the ,3-3 hexamer in the FoF1 motor with
the torque of 42pNnm was predicted by many lines
of evidence.10) The rotation of . was directly
demonstrated in single-molecule studies using ,3-3.
from TF1.11) Rotational motion was visualized by
attaching a ﬂuorescently labeled actin ﬁlament (1–
4µm) to .S107C of artiﬁcially induced mutant .
subunit with the biotin-streptavidine bridge. The
,3-3 hexamer was immobilized on a glass surface of
Ni-nitrilotriacetate by artiﬁcially attaching decapoly-
histidine to -,11) and the ATP-driven rotation of
the . subunit was found to be anticlockwise when
F1 was observed from the Fo side (Fig. 1, upper
left).11),17)
The work performed by the rotating . in a ﬁxed
,3-3 is the frictional torque times angle of rotation.
The hydrodynamic frictional drag coeﬃcient (9)o f
the actin ﬁlament for the propeller rotation is given
by 9 =( :/3)2L3/[ln(L/2r) − 0.447], where, 2 (10−3
Nsm −2) is the viscosity of the medium, L, the length
of the actin ﬁlament (1–4µm) and r, the radius of the
ﬁlament (5nm).11) The observed rates of ﬁlament
rotation at 2mM ATP are 7, 1, and 0.1 revolutions
per second, when the lengths of f-actin are 1, 2 and
4µm, respectively.11) The frictional torque 9B was
about 40pNnm, where B is the angular velocity.11)
Hydrolysis of one ATP molecule drives a 120°
rotation of the . subunit relative to the cylinder of
the ,3-3 hexamer, and therefore, hydrolysis of three
ATP molecules is required for one complete 360°
revolution.15),62) In order to analyze rapid rotation
by reducing the viscosity resistance of long actin
ﬁlament, ﬂuorescent gold beads (40nm) were at-
tached to .. At nanomolar ATP concentrations, -E
waits until the next ATP molecule is bound, and the
duration of the pause depends on the ATP concen-
tration (ATP-waiting dwell time).62) ATP binding to
-E is the power step that drives the 80° rotation of
..55) This rotation leads to simultaneous release of
ADP from the catalytic site of -D, and hydrolytic
cleavage of ATP into ADP and Pi at -T after a pause
(catalytic dwell time), and a 40° rotation occurs to
complete the 120° rotation.62)
Using mutant - (E190D) of TF1, in the same
rotational experiments, the catalytic activity of each
- subunit was shown to be coordinated with the
other two - subunits to drive rotation of the -E, -D,
and -T cycle.63) Hybrid F1 containing one or two
mutations with altered catalytic kinetics rotates in an
asymmetric stepwise fashion with diﬀerent dwell
times. Analysis of the rotation revealed that for any
given - subunit, the subunit binds ATP at 0°, cleaves
ATP at approximately 200° and carries out a third
catalytic event at approximately 320°. This demon-
strates the concerted nature of the F1 complex
activity, where all three - subunits participate to
drive each 120° rotation of the . subunit with a 120°
phase diﬀerence.63)
3.4. Torque-driven ATP synthesis by TF1.
ATP is synthesized by mechanical energy applied
on the . subunit without proton ﬂux. ATP
synthesis driven by mechanical energy (Fig. 1) was
directly shown by attaching a magnetic bead
(diameter = 700nm, biotinylated) to the . subunit
of ,3-3. of mutant TF1 (C193,,H 10--, and S107C.,
I210C.) on a glass surface, and rotating the bead
using electrical magnets.64) After the ATP-driven
rotation of the beads was conﬁrmed, the magnet was
turned on and several bursts of hundreds of
revolutions at 10Hz were imposed.64) Anticlockwise
forced rotation of the . subunit by the magnetic
beads resulted in the appearance of ATP in the
medium, as detected by counting the photons
emitted from the luciferase–luciferin reaction with a
camera (Hamamatsu Photonics).64) This shows that
torque working at one particular point (.)o na
protein complex can inﬂuence a chemical reaction
occurring at physically remote catalytic sites (-),
driving the reaction far from equilibrium.64)
4. Genes for TFoF1 and HFoF1: Single operon vs.
nuclear and mitochondrial genes
Detailed genetic analysis and site-directed muta-
genesis have been reported by Futai using E. coli FoF1
(EFoF1), as E. coli genetics are well understood.18),65)
The catalytic, structural and regulatory signiﬁcance
of an amino acid residue in EF1 was elucidated by
site-directed mutagenesis.65) However, many crucial
experiments, including the planar FoF1 bilayer51)
and torque-driven ATP synthesis,64) have not been
successful to date with EFoF1, due to its fragility.
Thus, a special sequencing method for thermophilic
genes was developed.66) The structure of the TFoF1
operon (number of amino acid residues),12),19) I(127)-
a(210)- c(72)- b(163)- /(163)- ,(502)- .(286)- -(473)-
C(132), was similar to that of the EFoF1 operon.18),65)
Amino acid residues in the diﬀerent ,, -, and .
subunits from TF1,12),19) HF1,21),27),28) BF1
24) and
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18),65) are aligned19) and expressed in the format
,10, which refers to residue #10 in the , subunit.
The residue numbers of amino acid sequences in the ,
and - subunits of TF1 are shown in Fig. 4 (dots
indicate every tenth residue).17),19) Primary struc-
tures are homologous, with 59% sequence identity
between thermophilic ,/human , and 68% between
thermophilic -/human -.19) The primary structure
of the TF1 - subunit showed homology with 270
residues which are identical in the - subunits from
HF1,C F 1, and EF1.19) The homologies of the amino
acid sequence between BF1 and YF1 were 73%, 79%
and 40%, respectively, for the ,, - and . subunits.14)
As these YF1 subunits were functionally comple-
mented with corresponding BF1 subunits,8) the
essential structure is conserved among YF1,B F 1
and HF1 (sequence is nearly identical to that of
BF1, but there were polymorphisms in HF1).8)
Residues forming reverse turns (Gly and Pro) were
highly conserved among the - subunits.19) Conserved
residues (green and blue letters in Fig. 4) among TF1,
HF1 and EF1 are closely related to catalytic and
regulatory functions.19),21),65) The observed substitu-
tions in the thermophilic subunit increased its
propensities to form secondary structures, and its
external polarity to form tertiary structure.19)
Chemical and genetic modiﬁcation of residues
in F1 revealed a nucleotide-binding P-loop
(-GGAGVGKT-; thermophilic -158–165 corresponds
to bovine -156–163) (Figs. 4, 5A).7),9),12),19),54) Long
before the X-ray crystallographic elucidation of the
P-loop,9) site-directed mutagenesis of the TF1 gene20)
to induce thermophilic -K164I and thermophilic
,K175I, identiﬁed an essential role for lysine residues
in the catalysis (Fig. 5A, red letters).20) The proton
abstracting thermophilic -E190 (Fig. 5A) localized
in the GER-loop (-VGER-) (Fig. 4)7),19),54) was also
predicted by TF1 mutagenesis producing thermo-
philic -E190Q.67) These mutant TF1 subunits pro-
duced an ,3-3. complex that was suitable for
Fig. 4. Aligned amino acid sequences12),19) and secondary structure elements71) of , and - subunits in TF1. Solid black lines indicate
folds, and these were classiﬁed into ,-helices (A–H, 1–8) and --sheets (a–f, 0–8). The labels for folds are provided only for the -
subunit, except for the three C-terminal ,-helices in the , subunit. Dots indicate every tenth residue. I–XI: areas of ,- contact. Red:
catalytic contact areas of -. Pink: catalytic contact areas of ,. Blue: non-catalytic contact areas of -. Green: non-catalytic contact
areas of ,. Colored bars indicate contact residues in T-E. Sequences are divided by red asterisks (*) to indicate the three domains.
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Species-speciﬁc residues (black letters in Fig. 4)
may have phylogenic components, including thermo-
philic loops (-ARNENEV-) (Fig. 4, ﬁrst line I′) that
render TF1 stable.19) Since determining the nucleo-
tide sequence of TFoF1,7),12),19) numerous rotating
ATP synthases of thermophilic F-type or V-type
(vacuolar ATPase) have been sequence and charac-
terized.65),68)
In contrast to the single operon TFoF1, the gene
structure of HFoF1 is highly complex21),26),28); most
subunits are encoded by nuclear DNA, with signal
peptides to target this protein to the mitochondrial
inner membrane,21),27),28) but subunits a and A6L of
HFo are encoded by mitochondrial DNA.21),26) The
complete sequence of the 16,569-base pair human
mitochondrial DNA contains genes for 12S and 16S
rRNAs, 22 tRNAs, ATPase subunits 6 (correspond-
ing to the a subunit of HFo) and 8 (corresponds to
A6L of HFo), and 11 other protein coding genes.26)
5. Crystallographic analysis of FoF1: Detailed
structure of H+-driven and ATP-driven motors
5.1. Crystallization and analysis at Photon
Factory. The most detailed structural information
for amino acid residues in a protein is obtained by
crystallographic analysis. In 1977, a two-dimensional
crystal of TF1 showed the pseudo-hexagonal struc-
ture of ,3-3.69) Three-dimensional crystals of TF1
(Fig. 5B) and ,3-3 hexamer (Fig. 5C) were obtained
using dye-ligand chromatography columns.70),71) The
high resolution power of the Photon Factory
synchrotron (for TF1 ,3-3, 0.32nm resolution at
Tsukuba) revealed the detailed structure of ,3-3.,9)
,3-3 (Fig. 5D),71) the c-ring,14),72) the peripheral
stalk,25) central stalk29) and the stator (Fig. 2).73)
X-ray crystallography (0.325nm resolution) of the
,3-3.C complex of EF1 was also recently reported
(Ducan, T.M., personal communication, 2010). The
peripheral stalk consists of a continuous curved ,-
helix about 16nm in length in the single b-subunit,
augmented by the predominantly ,-helical d and F6
(Fig. 2, right).25)
5.2. Crystallography of Fo. The c subunits
form a ring around a central pore.14),72) The numbers
of the c subunit in the Fo ring diﬀer depending on the
species: in CFo,i ti s1 4 , 72) while that for YFo
14) and
TFo is 10.15) The conserved carboxylates E61 of CFo
(corresponds to E56 of TFo) involved in proton
transport, are 1.06–1.08nm apart in the c-ring rotor,
which rotates relative to the membrane anchored a
subunit. The torque-generating unit consists of the
interface between the rotating c-ring and the ﬂanking
stator a subunit.14),72) The ring rotor is driven by the
sequential protonation and reprotonation of E61.
Residues adjacent to the conserved E61 residues
Crystals of α α3β3
Crystal of  TF1
A
B
C
D
Fig. 5. Crystals of TF1 and ,3-3, and X-ray crystallography data for the catalytic center of F1. A. Catalytic center of the - subunit of
BF1 (black text indicates residue number)9) and TF1 (red text indicates residue numbers).12) Except for ,R373 and ,S344, all of the
amino acid residues are present in -. Residues 159–164 are part of the P-loop surrounding the triphosphate residue of ATP. B.
Crystals of TF1.70) C. Crystals of ,3-3.71) D. Top view of the crystallographic structure of ,3-3.71)
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gen bonding.72) Upon deprotonation, the conforma-
tion of E61 is changed to another c subunit and
becomes fully exposed to the periphery of the ring.72)
Reprotonation of E61 by a conserved R in the
adjacent a subunit returns the E61 to its initial
conformation.72) Genetically modiﬁed TFoF1s, each
containing a c subunit dimer (c2) to a dodecamer
(c12), were prepared by genetical cross-linking.15)
Among these, TFoF1s containing c2,c 5,o rc 10 showed
ATP-synthesis and other activities, but those con-
taining c9,c 11 or c12 did not. Thus, the c-ring of
functional TFoF1 is a decamer (c10).15) When TF1 was
removed from the modiﬁed TFoF1s, TFos containing
only c2,c 5 or c10 worked as proton channels.15) In fact,
a 36° step size of proton-driven c10-ring in FoF1 was
conﬁrmed.16) The c10 ring in YFo
14) and functional
complementation of the YF1-deleted yeast mutant
with BF1 genes strongly suggests the presence of the
c10 ring in HFoF1.8)
5.3. Crystallography of catalytic site of F1.
The basic ground state of F1 without nucleotides was
shown on crystallography of the thermophilic ,3-3
hexamer,55) in which three ,1-1 dimers55) were
arranged in three-fold symmetry, 12nm across and
10nm high (Fig. 5D).71) The ﬁrst detailed crystallog-
raphy of nucleotide-bound ,3-3. (partial) of BF1 was
determined at 0.28-nm resolution by Walker’s
group.9) In the structure of BF1 crystallized in the
presence of ligand (AMPPNP:ADP:Pi = 50:1:0, and
Mg2+), the three catalytic - subunits diﬀered in
conformation and in bound nucleotide. There were
four unhydrolyzable ATP analogue (AMPPNP)
molecules, three in equal three , subunits, one in -
(-T) and one ADP in - (-D); the remaining - was
empty (-E).9)
The ATP-binding site of -T is surrounded by the
residues shown in Fig. 5A (black numbers for BF1 are
identical to those of HF1, red numbers for TF1).9),71)
In the P-loop of -T of TF1, the essential K16420)
forms hydrogen bonds with the phosphate of the
nucleotide, and the oxygen of T165 coordinates with
Mg2+, while in the GER-loop, E190 interacts with
water (Fig. 5A).9),71) The catalytic activity of -
requires , that supplies thermophilic ,-R365 and
thermophilic ,-S336 to the ATP-binding site at the
,- interface (Fig. 5A).9),71),74) The positive charge of
,-R365 stabilizes the --phosphate of AT(D)P, and
R256, R191 and K164 of thermophilic - interact with
the negative charges of the phosphates of AT(D)P
(Fig. 5A). The cross-linking of thermophilic -Y341
with azido-ATP7),54) predicted a hydrophobic inter-
action between the adenine ring, and Y341, F414 and
F420 (Fig. 5A).9),71)
5.4. Basic structure of ,3-3 is rendered
asymmetric by addition of . and/or nucleotides.
The basic structure of F1 is a symmetrical ,3-3
hexamer that is composed of three pairs of alternat-
ing ,E and -E (Fig. 5D).71) However, the asymmetry
induced by introduction of . and/or AT(D)P to
,3-3 hexamer is critical in the mechanism of ATP
synthesis.9) The nucleotide-free -E in both the F1
crystal9) and solution56) has an open structure
(Fig. 6) that is essentially identical to -E in the
nucleotide-free ,3-3 hexamer.71) Both -T and -D,a s
well as ,T, assume closed structures (Fig. 6, direction
of the open arrow).9) Interconversion of the open-
close conformational states of - is achieved by
addition of AT(D)P to the isolated -E of TF1.6),56)
However, nucleotide-free YF1 contained -D and -T
structures similar to those of nucleotide-bound
BF1.75) This suggests that -. interactions at the
three contact points (Fig. 6, middle, .1–3), including
interaction of Arg residue at position 75 (.R75) with
-DE395 in the DELSEED sequence of BF1 to change
the mutual conformation,10),14) are as important as
nucleotide occupancy in converting open -E into the
closed -.75) As genes for ,, - and . of YF1 in the
,---. deleted mutant yeast are complemented with
those of BF1,8) the functional residues are essentially
equal between YF1 and B(H)F1. Occupancy of the
catalytic site by ATP or ADP can be mimicked by
convenient BeF3-ADP complexes that bind to the
catalytic sites of -T and -D.76) The structure is
representative of an intermediate in the reaction
pathways.76) The conformational change of - induced
by .-rotation is essential for ATP synthesis (ATP
release from the catalytic site), while that induced by
ATP-binding to - is necessary to elicit torque on
..74),75)
5.5. Three domains in , and -: - barrel,
nucleotide-binding and ,-helical bundle do-
mains. The overall molecular structure of , and -
can be divided into three domains9),71),75):a nN -
terminal - barrel (Fig. 6, top N to *), a central
nucleotide-binding domain (Fig. 6, middle * to **),
and a C-terminal ,-helical bundle (Fig. 6 bottom **
to C).7) The locations of amino acid residues in the
,-helices (Fig. 4, solid black lines A–H, 1–8) and
--sheets (Fig. 4, solid black lines a–f, 0–8)71),74) are
compared in the three-dimensional structure of
thermophilic - (Fig. 6). As the amino acid sequence
of BF1
24) is nearly identical to that of HF1 (99%
homology in -),19),21) the following discussion on BF1
Y. KAGAWA [Vol. 86, 676is also applicable to HF1. Superposition of the overall
crystallographic structures of thermophilic -E and
bovine -E or bovine , revealed that the folding of
these structures is very similar.9),71) The - barrel
domains (Fig. 4, T, 21–94, T-1–82) contain six -
strands (Fig. 6. plate form arrows, -a–-f).74) The
nucleotide-binding domains (T ,95–371, T-83–354)
consist of nine-stranded --sheets surrounded by eight
,-helices (Fig. 6, ,At o,H) and a small antiparallel
--sheet. The C-terminal ,-helical bundle domain of ,
(thermophilic ,375–502) contains six helices (Fig. 4,
,1, 2, 4, 6–8), while that of - (theromophilic -355–
473) consists of six ,-helices (Fig. 4, ,1–6). Thus, the
largest diﬀerence between , and - is found in the C-
terminal region,9),74) and the DELSD(E)ED sequence
localized in this region was shown to be the most
important -. contact area.10)
5.6. Catalytic and non-catalytic ,- interfa-
ces and conformational change. The crystal
structure of BF1
9) and ,3-3 of TF1
71) indicates that,
in general, the conserved residues lie on the ,-
interfaces, as shown by detailed homology search
among TF1,H F 1,C F 1 and EF1.19) There are two
types of ,- interface that contain either a catalytic
site or non-catalytic site.9),74),75) The area where pairs
of residues connecting the ,- interface are located is
deﬁned as contact area. Contact residue pairs within
a limit of 0.40nm across the ,- interfaces in BF1
and the ,3-3 hexamer of TF1 were analyzed by a
computerized atom search using the CCP4 Suite:
Program Contact.74) The contact areas composed of
homologous residue pairs found in both TF1 and BF1
were deﬁned as homological contact areas. The
contact areas found only in one species, such as the
thermophilic loop of TF1 (I′ in Fig. 4) were deﬁned as
species speciﬁc contact areas. These areas are ex-
pressed as primary structure in Fig. 4. The contact
areas are located in both - and , at catalytic (red
and pink bars in Fig. 4), and non-catalytic (blue and
green bars in Fig. 4) interfaces. There are seven
catalytic (red I–III, V–VIII in Figs. 4 and 6) and non-
catalytic (blue I–VII in Figs. 4 and 6) contact areas
on the open - form (-E). The number of contact areas
on closed - (-D and -T) increased to 11 (red I–XI in
Fig. 6) and 9 (blue I–IX in Fig. 6), respectively, in
the catalytic and non-catalytic interfaces. The barrel
domain harbors the universal contact areas I and
II (Fig. 6, upper), and the common electrostatic
bond in II is thermophilic -R72–thermophilic ,E67
(=human -R71–human ,E67).9),71) At the catalytic
nucleotide-binding domain, areas III, V, VI, VII and
VIII are universally detected (Fig. 4). However, in
T-E, the P-loop contact area IV is latent, in contrast
to that area in thermophilic ,E (Fig. 6). Human
,R373 interacts with oxygen in the -- and .-P of
ATP bound at IV.9) In V, the common electrostatic
bonds are thermophilic -R193–,D339. In VI and VII
of -T and -D, human ,F299–-M222 and human
,S344–-R260, respectively, interact. However, we
identiﬁed no direct contact in the ,-helical bundle
domain in -E of TF1.74) In the catalytic ,- interface
of human -E, the contact areas (17.6nm2) are
Fig. 6. Three-dimensional structures of T-E. Three-fold axis is vertical, so that views are towards the ,- subunit interfaces. Left: non-
catalytic interface (blue I–IX indicates contact areas). Right: catalytic interface (red I–XI indicates contact areas). Green letters:
domain names, with domain borders being marked by red asterisks. D and R in green circles are T-D331 and T-R333, respectively, at
the entrance to the crevice of the P-loop. I in red circle is T-I386 of -- contact. H and G in yellow circles indicate hinge residues in T-
(179–181).74)
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areas in human -D (30.3nm2) and human -T
(22.0nm2) are increased to 11 and 10, respectively.
This is caused by the 30° upward motion of the C-
terminal domains.
5.7. Catalytic sites. The catalytic ,- interface
is located on the left side of - in the ,3-3 hexamer
(Fig. 5D), and the structure of catalytic domain
(Fig. 5A) is strictly conserved among spe-
cies.7),9),71),74) The catalytic domain accommodates
the P-loop located between sheet 3 and helix B
(T-163–178) and the conserved thermophilic -E190
(=human -E188) in the GER loop localized between
--sheet 4 and N-terminal end of ,-helix C9) (Fig. 4,
GER, and Fig. 6, middle). As predicted by X-ray
crystallography of AMPPNP-BF1,9) NMR analysis
revealed that thermophilic -R191 (Fig. 5A, upper
left) forms a hydrogen bond with the .-phosphate of
ATP.56) Pi is shown to bind the catalytic domain of
-E,62),75) which is identical to the sulfate binding site
of -E in ,3-3 by -K164 and ,R365.71) The structure
of the active metal-ATP complex in TF1 at the
catalytic domain was shown to be ", -, .-bidentate
Mg-ATP.77) (Rp)-[-.-18O, .-18O]ATP.S was hydro-
lyzed by TF1 in H2
17O, and the resulting inorganic
[16O, 17O, 18O] thiophosphate was shown to have an
Rp conﬁguration.77) The reaction thus proceeds with
inversion of conﬁguration at the phosphorous, and a
direct in-line nucleophilic attack of the 17O in water
on the .-phosphate of ATP via the pentavalent
intermediate state.77) The ordered water molecules
that carry out nucleophilic attack on the .-phosphate
of ATP during hydrolysis are 0.26nm from the
nucleotide analogue, beryllium, in the -D and 0.38nm
away in -T, strongly indicating that -D is the
catalytically active conformation.76)
Adjacent to the P-loop, there is a hinge point,
-HGG (179–181), between ,-helix B and --sheet 4
(Figs. 4, hinge, and Fig. 6, right). The conforma-
tional change in the hinge should be transmitted to
the DELSDED sequence in ,-helix I. The hinge
motion of the C-terminal domain containing the
DELSDED sequence in thermophilic -E, rotated
away from the core axis from 110° (close) to 144°
(open)56) In the reverse reaction, the resulting
widening of the P-loop–thermophilic -E190 distance
causes the release of Mg-ATP from the catalytic site.
Crystallographic analysis of the F1–IF1 complex
(IF1: natural inhibitory peptide) at 0.28-nm resolu-
tion revealed that IF1 binds in the ,D–-D interface
and opens the catalytic site.78) Inhibitor studies on F1
are thus important in understanding the formation of
dimeric HFoF1 and prevention of futile ATP loss
when "7H+ is decreased, as described in section 10.
6. Nanotechnological analysis of TFoF1 by single-
molecule imaging: Dynamic movement of FoF1
X-ray crystallography of F1 and FoF1 is a static
snapshot of inhibited ATPase crystallized in the
presence of AMPPNP9) or BeF3,76) or in the absence
of nucleotides.71),75) These crystals do not represent
the transient movement of subunits of TF1 during .-
rotation, or activity of TFoF1 in a liposome.3),39),46)
Thus, the dynamics of rotating TF1
79) or ATP
synthesis in FoF1-liposomes80) must be measured by
using TF1 containing mutant - subunits,63) and also
using modalities such as ﬂuorometry79),80) or NMR.56)
The eﬃciency of ﬂorescence resonance energy
transfer (FRET) between a donor and an acceptor
ﬂuorophore depends on their distance.16),79),80) If two
ﬂuorophores are bound to appropriate amino acid
residues in rotor and stator subunits, relative subunit
movements can be observed in real time by confocal
microscopy.16),79),80)
6.1. Nanomotor movement analysis by sin-
gle-molecule FRET. In a single TF1 molecule ﬁxed
on a glass surface,11),63) a donor ﬂuorophore (Cy3)
was bound to one of the three -s and an acceptor
ﬂuorophore (Cy5) was bound to the protruding
portion of ., and single pair (Cys3–Cys5) FRET
was performed to estimate the waiting conformation
during ATP hydrolysis.79) As Cy3- and Cy5-male-
imide are bound to cysteine residues, site-directed
mutagenesis [,(C193S), -(S205C) and .(S107C)]
was performed to bind Cy5 to -, and to bind Cy3
to ., and to prevent binding of Cy3 and Cy5 to ,
(residue numbers of , and - are indicated in
Fig. 4).79) The sole cysteine in a mutant subcomplex
of TF1, ,(C193S)3-(His-10 tag at N terminus) 3.
(S107C), was labeled with Cy5-maleimide. The (Cy5-
.)TF1 was incubated with Cy3--(S205C) at 1:10 at
45°C for 2 days, and the free - subunit was removed
on a size exclusion column.79) The energy of the laser
beam (532nm) on Cy3 was transferred to Cy5 and
emitted light (670nm) when the Cy3–Cy5 distance
was small, while only Cy3 light (570nm) was emitted
when the Cy3–Cy5 distance was great. FRET yield
changed cyclically as . rotated and the Cy3–Cy5
distances were estimated during the conformation
change.79) The distance between the two dyes
changed continuously as 5.7, 7.9, and 7.9nm during
rotation at low ATP concentrations, and the
conformational change corresponded to the ATP-
waiting state of TF1.79)
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synthesis has also been measured by FRET between
two ﬂuorophores bound to a stator subunit (b-
subunit) and a rotor subunit (.-o rC- or c-subunit)
(Fig. 1).62),80) The labeled FoF1 was reconstituted in
the liposome (one FoF1 per liposome) and "7H+ was
applied, so that FoF1 carried out H+-driven ATP
synthesis.46) Analysis of the time course of FRET
eﬃciency in the FoF1-liposome showed the rotation of
.- and C-subunit relative to b-subunit in 120° steps,80)
and that of the c10-ring in 36° steps.16) The - motions
through an attached ﬂuorophore, concomitantly with
the 80° and 40° substep rotations of . in the same
single molecules, showed the sequence of conforma-
tions that each - undergoes in three-step bending, an
approximately 40° counterclockwise turn followed by
two approximately 20° clockwise turns, occurring in
synchronization with two substep rotations of ..80)
The results indicate that most previous crystal
structures mimic the conformational set of three -s
in the catalytic dwells,80) while the previously
described set of -E, -D and -T was revealed in the
ATP-waiting dwells.80) These ﬂuorescent studies thus
bridge the gap between the chemical and mechanical
steps in FoF1. Starting from the ATP-waiting dwell
(0°), the 80° and 40° substeps of . rotation are
induced by ATP binding and ADP release, and ATP
hydrolysis and Pi release, respectively.62),79)–81)
6.2. H+/ATP ratio and elastic power trans-
mission in FoF1. One of the unsolved questions in
the mechanistic study is the analog–digital conver-
sion of energy in FoF1. The electrochemical energy of
the H+ current1) through FoF1 in liposomes3) and
planar bilayers,51) and the electric,48),50) magnetic64)
and mechanical energy of the rotation11),62) are all
analog quantities. The numbers of ATP molecules
synthesized and protons transported are digital
quantities. Thus, the elastic power transmission in
FoF1 analog/digital conversion during the .-rotation
was predicted in 1996.10) Oosawa also proposed a
loose coupling mechanism in which the number of
protons necessary for the synthesis of one ATP is not
an integer but varies depending on the environmental
conditions.61) As one proton is translocated by one
shift of c10 in the c-ring of TFoF1,15),16) and one ATP
is synthesized per - subunit of TF1, the inevitable
consequence is noninteger ratios of rotation step sizes
for TFoF1 (120°/36°) and for H+/ATP (10:3).14),15),74)
This step-mismatch necessitates elastic twisting of
TFoF1 during rotation and elementary events in
catalysis.7),74) The H+/ATP ratio in FoF1 addresses
this analog/digital problem. Fosw i t hc 10 ring are
present in organisms that maintain "7H+ mainly in
the form of "A,14),15) whereas Fos with c14 ring are
mostly found in species with "7H+ existing predom-
inantly in the form of "pH rather than "A.72) H+/
ATP ratios of 4.7 and 3.3 are thus expected for CFoF1
(with 14c/3-)72) and E(T)FoF1 (with 10c/3-),14)–16)
respectively. To conﬁrm the eﬀects of c/- subunit
ratios on H+/ATP ratio, pH of the internal phase of
the reconstituted FoF1-liposomes was equilibrated
with acidic medium.46),47) Then, an acid-base tran-
sition46) was induced by adding alkaline medium to
the liposomes to produce "pH across the membrane,
and the initial rate of ATP synthesis was measured
with luciferase.82) From the shift in the equilibrium
"pH as a function of Q (= [ATP]/([ADP][Pi]), the
standard Gibbs free energy for phosphorylation,
"Gp
0′, and the H+/ATP ratio were determined.82)
The results were as follows: "Gp
0′ =3 8±3k J /mol
and H+/ATP = 4.0 ± 0.2 for CFoF1; and H+/
ATP = 4.0 ± 0.3 for EFoF1. This indicates that the
thermodynamic H+/ATP ratio is the same and that
it diﬀers from the subunit c/- stoichiometric ratio.82)
However, in order to estimate actual energetics, the
very low turnover rates (<1 ATP/s) in this experi-
ment82) need to be examined under diﬀerent physio-
logical conditions (>100 ATP/s).
The site of analog–digital conversion by elastic-
ity7) was estimated by direct measurement of the
torsional stiﬀness.83) Most parts of F1, particularly
the central . shaft in F1, and the long eccentric
bearing had high stiﬀness (torsional stiﬀness 5 >
750pNnm).83) One domain of the rotor, namely,
where the globular portions of . and C contact the
c-ring, was more compliant (5 congruent with
68pNnm).83) The .-induced or nucleotide-dependent
open–close conversion of conformation is an inherent
property of an isolated -, and energy and signals are
transferred through ,- interfaces.7),11),74) Rotation of
the central shaft . in ,3-3 hexamer is assumed to be
driven by domain motions of the -s. These - motions
were directly observed through an attached ﬂuoro-
phore by FRET79),80) and NMR.56)
The mechanisms underlying the open(-E)–
close(-T) motion were investigated for - subunit of
TF1 in solution, using mutagenesis and NMR.56) The
hydrogen bond networks involving side chains of
K164 (162 for human - is shown in parentheses),
T165(163), R191(189), D252(256), D311(315) and
R333(337) in the catalytic region (Fig. 5A, red text
for TF1 and black text for HF1)74) are signiﬁcantly
diﬀerent for the ligand-bound and free - subunits.56)
The role of each amino acid residue was examined by
ATP synthase: from single molecule to human bioenergetics No. 7] 679A (alanine) substitution.56) The chemical shift
perturbation of backbone amide signals of the
segmentally labeled -(mutant)s indicated stepwise
propagation of the open/close conversion on ligand
binding.56) Upon ATP binding, the open/close
conformation change regulated by hydrogen-bond
switching from K164/D252 to T165/D252 (Fig. 5A,
right upper, red test) would take place in the
thermophilic - subunit because ATP-binding is the
major driving force for the ﬁrst 80° rotation.62) The
resulting closing motion of the hinge (-HGG-)
between ,-helix B and --sheet 4 (Fig. 6, right)
generates the torque of . rotation through the
DELSD(E)ED contact point (Fig. 6, bottom).10),56)
Although the time scale of atomic ﬂuctuations is in
the order of tens of nanoseconds, molecular simu-
lation will solve the detailed movements of residues in
,3-3 during the . rotation (order of milliseconds) in
the future.
7. Biogenesis of human FoF1: Regulated
expression, splicing, import and assembly
The biogenesis of HFoF1 is an intricate proc-
ess,21) starting from transcription,84)–86) splicing of
nuclear encoded subunits (Fig. 7),27),32) and trans-
lation of mitochondrial DNA-encoded subunits
(Fig. 8)22),26),87) and nuclear DNA-encoded precursor
peptides for all F1 subunits (,, -, ., / and C)21),86) and
7F o subunits (b, c, d, e, f, g and OSCP),21) followed
by targeting, importing and processing of nuclear
DNA-encoded precursor peptides in the mitochond-
rion (Fig. 9).21),86) Precursor importing requires both
"7H+ to drive translocation and speciﬁc carrier
proteins in the outer and inner mitochondrial
membrane, as well as general chaperones present in
the cytosol and mitochondrial matrix.86) Processing
of the presequence of precursor requires a speciﬁc
protease,86) and after the removal of the presequence,
nuclear-encoded subunits are assembled into HFoF1
with two mtDNA-encoded Fo subunits (a and
A6L).87) Targeting the presequence of three isoforms
of subunit c liberated after proteolysis is required for
the assembly of cytochrome oxidase.88)
As both the amino acid and nucleotide sequences
of subunits in HFoF1 are available in internet
databases, only physiologically important points
A
B
C
Fig. 7. Alternate splicing of human F1. pre-mRNA. A. Exons in the F1 . pre-mRNA are expressed in boxes. Exon number 8 (hatched
box) is included in liver and excluded in the muscle. B. Schematic representation of wild-type and mutant F1. exons 8–9 (Ex8–9).27)
Heavy underline in Ex9-wild-type indicates ESE element. Mutated nucleotides are indicated by outlined letters. In Ex9-MU2 and
Ex9-MU, boxed letters indicate that these sequences are predicted to act as ESE elements. C. Selection of F1. exon 9 is regulated by
two cis-acting regulatory elements in the same exon.90) Purine-rich ESE promotes exon 9 inclusion, which is repressed by MS-ESS
under muscle-speciﬁc conditions; PPT: Polypyrimidine tract.
Y. KAGAWA [Vol. 86, 680in the biogenesis of HFoF1 will be reviewed
here.21),28),86),89) In contrast to prokaryotic FoF1,
including TFoF1,7) proteomics have revealed a large
universe of pseudogene products,21),84) splice variants
(muscle-type F1.) (Fig. 7),27),32),90) post-translational
modiﬁcations (phosphorylated HFoF1, etc.),91) di-
meric HFoF1,30) a supramolecular complex called
ATP synthasome (Fig. 2),31) and ectopic HFoF1
(Fig. 10, right).92)
7.1. Expression of HFoF1 genes. The gene
structure of the HF1, subunit is 14kbp in length and
contains 12 exons interrupted by 11 introns.21),84)
Primer extension and S1 mapping analysis showed
the presence of multiple transcription initiation sites
in the HF1, gene.84) The 5′-ﬂanking region of the
HF1, gene has an unconserved GC-rich region,
including several binding motifs of transcriptional
factors, such as Sp1, AP-2 and GCF. The basal
promoter activity was located near the GC-rich
region. Comparison of the 5′-upstream region of the
HF1, gene with those of the genes for BF1,,H F 1-85)
and HF1.27) indicated three common sequences (CS1,
Fig. 8. Homoplasmy, heteroplasmy, cytoplasts and ;o cells.87) Small red circles indicate wild-type mtDNA and small blue circles indicate
mutant mtDNA; large red circles indicate nDNA, and green ovals indicate cells. EB: ethidium bromide used to remove mtDNA; PEG:
polyethylene glycol used to fuse cells or cytoplasts.
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ATP synthase: from single molecule to human bioenergetics No. 7] 681CS2 and CS3) in the regulatory regions,21) suggesting
that putative cis-elements coordinate the expression
of the three subunit genes for HF1.84)–86) The
enhancer activities derived from 5′-deletion mutants
of a HF1,-CAT (chloramphenicol acetyltransferase)
chimeric gene were diﬀerent in cell lines from four
diﬀerent human tissues, thus suggesting the existence
of cell type-speciﬁc gene regulation.21)
The HF1- gene is 14kbp in length and contains
10 exons, with the ﬁrst exon corresponding to the
non-coding region and most of the presequence,
which targets this protein to the mitochondria.85),86)
Eight Alu repeating sequences including inverted
repeats were found in the 5′-upstream region and
introns. An S1 nuclease protection experiment
revealed two initiation sites for transcription. Three
CCAAT boxes were found between the two initiation
sites, and two GC boxes were located in the 5′-
upstream region. Promoter activity was estimated by
the CAT method and an enhancing structure for
transcription was detected between nucleotides -400
and -1100 in the upstream region.86)
The system coordinating expression of nuclear-
coded mitochondrial proteins was investigated by
examining the 5′-ﬂanking region of the HF1- gene. In
one of the enhancing regions, a consensus sequence
was found for the genes of other mitochondrial
proteins, such as those for cytochrome c1 and the
pyruvate dehydrogenase ,-subunit.21),86) The char-
acteristics of this enhancing element were examined
by introducing a synthetic oligonucleotide element
into the CAT plasmid with a deleted enhancing
element. The resulting plasmid showed full recovery
of promoter activity, and this activity was independ-
ent of the orientation or location of the insert.
Therefore, this enhancer may be common to the
nuclear genes of some mitochondrial proteins in-
volved in energy transduction.21)
The functions of subunits in mitochondrial FoF1
were conﬁrmed by expression of genes in deletion
mutants, and their functional complementation.8)
The genes encoding BF1 subunits (except for those
of /) were expressed in a quintuple yeast YF1 deletion
mutant (","-"."/"C) after introduction of a
chimeric BF1 subunit gene construct that uses the
YF1 transcriptional promoter and termination sites,
as well as the presequence for YF1.8) Expression of
the ,-, --, .-, or C-subunit of BF1 complemented
the corresponding individual mutations in YF1. All
BF1 subunits (with chimeric /) expressed in yeast
produced an F1 that was puriﬁed to a speciﬁc activity
of about half of that of original BF1.8) These results
indicate that the molecular machinery required for
the targeting, proteolysis and assembly of the
mitochondrial FoF1 is conserved from yeast to
humans (Fig. 9).8) Similarly, bovine OSCP and some
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Fig. 10. Regulation of HF1Fo activity: Neuronal impulse from brain to human activity driven by ATP by an intricate regulation system.
AMPK, AMP kinase; ecto-F1Fo, ectopic or cell surface F1Fo; IF, ATPase inhibitor; METs, metabolic equivalents of exercise intensity;
Rs, receptors for neuro-endocrine transmitters; VDAC, voltage-dependent anion channel.
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(quoted in Ref. 8). In one functional study, the gene
for . subunit (atp-3) was partially blocked by RNA
interference (RNAi) in Caenorhabditis elegans, and
ATP levels decreased from 15nmol/mg protein
(control) down to 4nmol/mg, and the behavior
extended the lifespan.93) However, tissue diﬀerentia-
tion is absent in yeast, alternate splicing must be
studied in human cells.27),32)
7.2. Tissue-speciﬁc splicing of HF1.:
Analysis using transgenic mice and minigenes.
Mammalian FoF1 is characterized by tissue-speciﬁc
expression of the F1 gene, which was analyzed using
transgenic mice32) and minigenes in cultured human
cells.90) The muscle-speciﬁc isoform of HF1. was
generated by alternative splicing, and exon 9 was
found to be lacking in skeletal muscle and heart tissue
(Fig. 7, A).27) Using transgenic mice,32),90) the alter-
native splicing of exon 9 was shown to require de
novo protein synthesis of a cis-acting element on
the spliced exon of HF1. gene. An HF1. wild-type
minigene, containing the full-length gene from exons
8 to 10, and two mutants were prepared; one mutant
involved a pyrimidine-rich substitution on exon 9,
whereas the other was a purine-rich substitution
(abbreviated as HF1. Pu-del and HF1. Pu-rich
mutants, respectively).90) Pu-del inhibited exon
inclusion, indicating that a Pu-del mutation disrupts
an exonic splicing enhancer. On the other hand, Pu-
rich blocked muscle-speciﬁc exon exclusion.90)
Transgenic mice bearing both mutant minigenes
were then analyzed for their splicing patterns in
tissues.90) Based on an analysis of HF1. Pu-del
minigene transgenic mice, the purine nucleotide in
this element was shown to be necessary for exon
inclusion in non-muscle tissue. In contrast, analysis of
HF1. Pu-rich minigene mice revealed that the HF1.
Pu-rich mutant exon had been excluded from heart
and skeletal muscles in these transgenic mice, despite
the fact that mutation of the exon inhibited muscle-
speciﬁc exon exclusion in myotubes at early embry-
onic stages.32) These results suggest that the splicing
regulatory mechanism underlying HF1. pre-mRNA
diﬀers between myotubes and myoﬁbers during
myogenesis and cardiogenesis.32)
A detailed mutational analysis of exon 9 (Fig. 7,
B) revealed a purine-rich exonic splicing enhancer
(ESE) element (5′-AAUGAAAA-3′) functioning
ubiquitously, with the exception of muscle tissue.
An exonic negative regulatory element responsible
for muscle-speciﬁc exclusion of exon 9 was discovered
using both in vitro and in vivo splicing systems.32),90)
Mutation analyses on the HF1. Ex8-9 minigene using
a supplementation assay demonstrated that the
muscle-speciﬁc negative regulatory element is posi-
tioned in the middle region of exon 9, immediately
downstream from ESE. Detailed mutation analyses
identiﬁed a muscle-speciﬁc exonic splicing silencer
(MS-ESS) (5′-AGUUCCA-3′) responsible for exclu-
sion of exon 9 in vivo and in vitro (Fig. 7, C).90) This
element was shown to cause exon 9 skipping of in vivo
splicing systems.90) Although there are three variants
of the c subunit88) and several alternate splice
variants in the human mitochondrial fusogenic
proteins (mitofusin 1, 2),87) the . subunit of HF1 is
the only well-characterized variant in FoF1.86),90)
8. Mitochondrial cytology of HFoF1: cytoplasts
lack nDNA and ;o cells lack mtDNA
HFoF1 is encoded by both mitochondrial DNA
(mtDNA)22),26),33) and nuclear DNA (nDNA)
(Fig. 9).21),86) In order to analyze the roles played
by mtDNA and nDNA, mtDNA-less cells (;o
cells)22),33) and nDNA-less cells (cytoplasts) were
developed (Fig. 8).87),94) Using ethidium bromide,
mtDNA was removed and the resulting ;o cells
became strictly dependent on glycolysis to compen-
sate for the oxphos that supplies ATP.33),87) Thus, a
glucose medium is essential for ;o cells.22) Cytoplasts
are enucleated cells that contain mitochondria
(Fig. 8, upper left), with examples being enucleated
oocytes,87) synaptosomes94) and platelets.94) Since
DNA sequence of an individual diﬀers from each
other owing to the genetic polymorphism of
mtDNA,21) personal collection of mtDNA is essential
to elucidate mitochondrial diseases. Human mito-
chondria with intact mtDNA have been directly
isolated from postmortem platelets.94) Expression of
nDNA-encoded HFoF1 subunits was not aﬀected in ;o
cells,87) while that of mtDNA-encoded HFo subunits
(Foa and A6L) was lost in cytoplasts, as nDNA-
encoded mitochondrial transcription factor A
(Tfam)95) was lacking (Fig. 9).87) The ;0 cells have
no respiratory chain, because of the loss of mtDNA-
encoded subunits of cytochromes and NADH dehy-
drogenase.26),87) Despite the absence of oxphos, ;o
cells require mitochondrial compartments with a
suﬃcient "7H+ for energy driven transport of matrix
components.87),96) The essential "7H+ of ;o cells is
maintained by the electrogenic exchange of ATP4−
for ADP3− by ANC.96) To energize the inner
membrane, ,3-3 (ATPase active)55) in the matrix
of ;o cells regenerates ADP from translocated
ATP.96)
ATP synthase: from single molecule to human bioenergetics No. 7] 683The term heteroplasmy refers to cells that
contain a mixture of mtDNAs with diﬀerent
sequences (Fig. 8, upper right), whereas homoplasmy
means that 100% of their mtDNA has an identical
sequence (Fig. 8, upper left).22),87) Cybrids were
formed by cytoplast fusion with ;o cells using
polyethylene glycol (PEG) (Fig. 8, bottom).87),94)
The majority of pathogenic mtDNA mutations are
heteroplasmic, with mutated and wild-type mtDNA
coexisting in the same cell (Fig. 8, upper right).86),87)
Owing to the absence of protecting histones, mtDNA
is highly susceptible to mutations that result in
heteroplasmy. Mutations in the tRNA gene of
mtDNA often block translation and cause complete
deletion of mtDNA-encoded proteins (syn− muta-
tion), including HFo subunits.87)
During development, cell division unevenly dis-
tributes heteroplasmic mtDNA into daughter cells
and eventually segregates homoplasmic cells with
wild-type and syn− mutant mtDNA (Fig. 8, bottom
right). This stochastic segregation of the syn−
mutation results in the syn− mutant concentrated
tissues and causes mitochondrial diseases, including
mitochondrial diabetes.87) The homoplasmic syn−
cells lack oxphos and depend on glycolysis. Under
the inﬂuence of polymorphisms in mtDNA and
nDNA, a vicious circle of reactive oxygen species will
damage cells. However, mitochondrial transfer from
wild-type homoplasmic cytoplasts by fusion to form
cybrids will normalize the diseased cells97) and syn−
mutation will be alleviated by mitochondrial fu-
sion.87),97) We analyzed heteroplasmy and polymor-
phisms related to diabetes and its complementation
by mitofusins.87) Mitochondria in human cells are
visualized as a network or as ﬁlaments that undergo
continuouschangesinshapeandinlocalizationwithin
the cells. Mitochondrial fusion proteins including
mitofusins87) and OPA198) that may work as natural
PEG in Fig. 8,87) and regulate both mitochondrial
fusion and metabolism. We characterized splice
variants of human mitofusins (also called hfzo 1, 2
and 3)87) as well as OPA1s (Fig. 10, upper right).98)
We analyzed complementation by fusogenic proteins,
and the lost tRNA in mitochondria of syn− mtDNA
inside heteroplasmic cells was complemented by wild-
type tRNA in normal mitochondria by fusing wild-
type and syn− mitochondria with mitofusins.87) The
mitofusin genes were expressed mainly in post-mitotic
brain and muscle, thus complementing mutated
mtDNA that is not removed during cell division.87)
In order to analyze a mitochondrial disease, pure
nuclear transfer was carried out from ;0 HeLa cells to
the ﬁbroblast lines from a patient with cardiomyop-
athy, and their nuclear hybrid clones were isolated.22)
A normal ﬁbroblast line from the fetus and a
respiration-deﬁcient ﬁbroblast line from the patient
were used as positive and negative controls, respec-
tively.22) By this method, many mitochondrial
diseases devoid of HFo have been elucidated87) and
mitochondrial gene therapy for heteroplasmic pa-
tients was developed using cytoplasts from a normal
fetal cells and the cybrids (Fig. 8).97)
The most frequent mutation in mtDNA-encoded
HFo gene is NARP (neuropathy, ataxia, and retinitis
pigmentosa), caused by a mutation at L156 in the a
subunit of HFo (Fig. 2).99) A mutation conferring a
milder phenotype (L156P) leads to a 30% reduction
in H+ ﬂux, and a similar loss in ATP synthesis. The
more severe mutation (L156R) also leads to a 30%
reduction in H+ ﬂux, but ATP synthesis is abol-
ished.99) With the L156P mutation, rotation of the c-
ring may be slowed, but coupling of ATP synthesis to
H+ ﬂux is maintained (Fig. 1, lower left, subunit a),
whereas with the L156R mutation, H+ ﬂux is
uncoupled, because the transmembrane helix III of
Foa is unable to span the membrane. The L156R
mutant has ATPase activity,99) because the ,3-3
complex portion of F1 is intact, and increased proton
permeability through the defective Fo cannot main-
tain "7H+ to inhibit ATP-driven H+ translocation
(i.e., uncoupling).3),46)
8.1. Coordination of nuclear and mitochon-
drial DNA. The tissue activity of FoF1 mainly relies
on mitochondrial biogenesis encoded by both nDNA
and mtDNA (Fig. 9). A number of transcriptional
modulators have been implicated in the regulation of
mitochondrial biogenesis and oxphos activity.84)–89)
To understand the nDNA–mtDNA interactions in
human cells, we identiﬁed the nuclear transcription
factors that are common to the expression of these
gene products. As Tfam encoded by nDNA is
essential for both the initiation of transcription and
the replication of mtDNA, we cloned and sequenced
the human Tfam gene.95) There were sequences in the
5′-upstream regulatory region of Tfam common to
those in HF1-.95) In the absence of mtDNA-coded Fo
subunits, expression of other FoF1 subunits was not
aﬀected, but most nDNA-coded subunits other than
, and - of FoF1 could not be assembled.87),96) For in
vivo analysis of this regulation, transmitochondrial
mice carrying various proportions of deletion mutant
mtDNA ("mtDNA) were generated by introducing
"mtDNA from cultured cells into the fertilized eggs
of mice.100) The great advantage of transmitochon-
Y. KAGAWA [Vol. 86, 684drial mice is that they share exactly the same nDNA
background and their genetic variations are re-
stricted to the proportions of pathogenic mtDNA.100)
Transcription factors in the expression of HFoF1
include PPAR. coactivator 1, (PGC-1,), in coop-
eration with several factors, such as peroxisome
proliferator-activated receptor (PPAR), nuclear res-
piratory factors 1 and 2 (NRF-1 and NRF-2), or the
speciﬁcity protein 1 (Sp1), a ubiquitous transcription
factor known to regulate the constitutive expression
of oxphos genes (Fig. 10, upper).86) PGC-1, is a
master modulator of gene expression in human
tissues and enhances the activity of PPAR, in
skeletal muscle.101) Mitochondrial transcription is
directed by a small number of nucleus-encoded
factors, including Tfam.95) Expression of these factors
is coordinated with that of nuclear respiratory
proteins through the action of PGC-1 family
coactivators.101)
Using these cytological methods (Fig. 8), tran-
scriptomics and proteomics (Fig. 9), human bioen-
ergetics at both cell level (Fig. 10) and in vivo levels
were elucidated.
9. Supramolecular structure of HFoF1: Dimeric
HFoF1, ATP synthasome and ecto-HFoF1
Mitochondrial FoF1, including HFoF1, is typi-
cally isolated as a monomeric complex that contains
16 protein subunits21) and the natural inhibitor
protein (IF1) (Fig. 2).78) However, mitochondrial
FoF1 was isolated in dimeric and higher oligomeric
states using digitonin for one step mild solubilization
followed by blue native (BN) or clear native (CN)
electrophoresis.102) Recent developments in proteo-
mics have revealed HFoF1 in its natural supra-
molecular state.30),31),102) Single bands in the gel can
be analyzed by proteomics approaches including
immunoprecipitation,103) and mass spectrometry to
identify the amino acid sequence of the compo-
nents.103) Electron microscopy of these oligomeric
mitochondrial FoF1 particles was reported in 1972
(Fig. 2C in Ref. 3). Dimeric and trimeric FoF1 were
puriﬁed from mammalian mitochondria in ﬁve diﬀer-
ent tissues by BN electrophoresis and CN electro-
phoresis,30),102) and these were active, thus suggesting
that oligomeric FoF1 is constitutive in mitochondria.
Using BN electrophoresis, two membrane proteins
(6.8kDa proteolipid and diabetes-associated protein)
that had previously been removed during puriﬁcation
were shown to be stoichiometrically associated with
FoF1,30) and this may provide insight for further
functional investigations.30)
In situ mitochondrial "7H+ was directly esti-
mated by rhodamine 123, which is accumulated in
mitochondria depending on "7H+.103) The futile
ATP hydrolytic activity of HFoF1 during ischemia
that lowers "7H+, is prevented by IF1.78) Bovine IF1
is an ,-helical dimer and residues 1–37 of IF1 open
the catalytic interface between ,D–-D.78) Atomic
force microscopy images show how these FoF1
molecules form dimers with a characteristic 15-nm
distance between the axes of their rotors through
stereo-speciﬁc interactions of the membrane-em-
bedded portions of their stators.104) Ad i ﬀerent
interaction surface is responsible for the formation
of rows of oligomers, suggesting the role of subunits e
and g of HFo in dimerization.104) Some dimers have a
diﬀerent morphology, with a 10-nm stalk-to-stalk
distance, in line with FoF1s, which are thus accessible
to IF1.104) Dimeric or polymeric HFoF1 is related
to morphology of cristae104) under the inﬂuence of
OPA1.98)
A channel protein, porin, is now known as
VDAC (voltage-dependent anion channel) and is the
most abundant protein in the mitochondrial outer
membrane.52) VDAC helps ATP/ADP exchange by
forming a complex with ANC (ANC–VDAC com-
plex).103) Finally, a supramolecular structure called
ATP synthasome composed of FoF1, ANC, PIC and
perhaps VDAC was isolated and characterized
(Fig. 2).31) Parallel immuno-electron microscopic
studies revealed the presence of PIC and ANC
located non-centrally in the basepiece, and other
studies indicated an ATP synthase/PIC/ANC stoi-
chiometry near 1:1:1 (Fig. 2).31) Collectively, these
ﬁndings support a mechanism in which the entry of
the substrates ADP and Pi into mitochondria, the
synthesis of ATP on HFoF1, and the release and exit
of ATP are localized in a supramolecular structure in
a highly coordinated system.
9.1. Ectopic HFoF1: plasma membrane local-
ization in lipid rafts. HFoF1 is located not only on
the mitochondrial inner membrane, but also on the
cell surface. Extracellular ATP synthesized by the
ectopic HFoF1 is not an energy source but a regulator
for various cellular responses that are initiated by
purinergic receptors (P2X and P2Y) and signaling
processes and are terminated by breakdown of ATP
by ectonucleotidases (Fig. 10, right). By using 3H-
ADP, net 3H-ATP synthesis by cell surface HFoF1
was conﬁrmed (to rule out ATP + AMP synthesis by
adenylate kinase). ATP synthesis was inhibited by
membrane-impermeable HFoF1-speciﬁc inhibitors
(angiostatin and piceatannol) and anti-HF1 anti-
ATP synthase: from single molecule to human bioenergetics No. 7] 685body.105) Immunoprecipitation indicated that ectopic
HFoF1 and a surface protein of endothelial cells,
caveolin-1, are physically associated.105) Adipocyte
ectopic HFoF1 may contain Fo, as it is inhibited by
oligomycin and inﬂuenced by a proton conductor
(uncoupler) (quoted in Ref. 92). HFoF1 is selectively
localized in lipid rafts with other mitochondrial
proteins. Lipid rafts are detergent-resistant mem-
brane microdomains enriched in cholesterol and
caveolin-1. Intracellular traﬃc may translocate
HFoF1 containing ,, -, ., b, d, F6 and OSCP from
mitochondria to lipid rafts.92)
The ectopic HFoF1 has been implicated in
numerous activities, including the mediation of
intracellular pH, cellular response to antiangiogenic
agents, and cholesterol homeostasis as a receptor for
apolipoprotein A-1.106) HFoF1 is expressed on the
surface of endothelial cells, where it binds angiosta-
tin, regulates surface ATP levels, and modulates
endothelial cell proliferation and diﬀerentiation via
purinergic receptor (Fig. 10, right).106)
Ectopic HFoF1 is closely related to obesity.107)
Expression of the , subunit of ectopic HFoF1 is
markedly increased during adipocyte diﬀerentiation.
Treatment of diﬀerentiated adipocytes with inhib-
itors of HFoF1 or antibodies against , and - subunits
of HFoF1 leads to a decrease in cytosolic lipid
accumulation.107) Apolipoprotein A-I binds to the -
subunit of ectopic HFoF1 and its inhibition decreases
the production of lipid droplets.107) Depletion of
plasma membrane cholesterol with methyl-beta-
cyclodextrin disrupts lipid rafts and abolishes co-
localization of HFoF1 with caveolin-1, which results
in a marked reduction in shear stress-induced ATP
release.105) Endothelial cells release ATP from ectopic
HFoF1 in response to shear stress, a mechanical force
generated by blood ﬂow, and the ATP released
modulates cell functions through activation of down-
stream signals to purinergic receptors.105) These
results suggest that the localization and targeting
of HFoF1 to caveolin-1/lipid rafts is critical for
shear stress-induced ATP release by endothelial
cells.105)
It remains uncertain how Fo components en-
coded by mtDNA are translocated to rafts as ectopic
HFoF1, particularly in the form of intact HFoF1
(Fig. 10, right). However, inter-organellar traﬃco f
mitochondrial proteins was clearly demonstrated
using green ﬂuorescent protein.103) These mitochon-
drial dynamics will be discussed in the ﬁnal section.
The energy source ("7H+) to synthesize ATP by
ectopic HFoF1 may not be respiration, but the
K+channel dependent resting potential of plasma
membrane is inside negative. These ectopic FoF1
activities have never been reported in prokary-
otic FoF1, although FoF1-like V-type ATPase is
widely distributed in prokaryotic and mammalian
membrane structures to transport ions.65),68) In
mammalian tissues, some proteins involved in energy
metabolism may exert entirely diﬀerent functions;
cytochrome c, for example, is an electron carrier
but also serves as the central signal protein in
apoptosis.
10. In vivo ATP synthesis: FoF1 in human
bioenergetics and diseases
The function and survival of all organisms is
dependent on the dynamic control of energy metab-
olism. Energy demand is matched to ATP supply by
FoF1 and glycolysis (Fig. 10, bottom).7),21) The
increase in ADP + Pi produced by ATP consump-
tion results in the instant "7H+-driven ATP syn-
thesis by FoF1 and increases in electron transport
activity to compensate "7H+ (respiratory control).
The increase in ADP is ampliﬁed as AMP increase by
myokinase reaction (2ADP = ATP + AMP). If ATP
synthesis by FoF1 is not enough, especially when
oxygen supply is limited by high metabolic equiv-
alents (METs >5), increased AMP/ATP ratio
activates phosphofructokinase to compensate ATP
by glycolysis. Although the regulatory mechanism of
TFoF1 is basically ubiquitous,7),108) HFoF1 is speci-
alized for human activity. One of the characteristics
of HFoF1 among other FoF1s is genetic poly-
morphisms during evolution, particularly in
mtDNA,87),109) that cause ethnic and interindividual
diﬀerences in physical activity, aging and disease
susceptibility.87),109) Voluntary will of the brain
triggers muscle contraction and other organ speciﬁc
activities that consume about 50kg of ATP per day,
but METs change from 0.9 to 15 in a normal adult
(Fig. 10, right). Direct measurement of in vivo HFoF1
activity and AMP/ATP ratio is possible by using 31P
magnetic resonance spectroscopy revealed that ATP
synthase ﬂux correlated with O2 uptake (METs) and
insulin sensitivity.110) The increase in METs is mainly
caused by actomyosin contraction (Fig. 10, right),
and muscle-speciﬁc . subunit splice variants of HFoF1
are seen during myogenesis and cardiogenesis
(Fig. 7).32),90) The resulting change in substrates to
increase lactic acid can be assessed by 1H magnetic
resonance spectroscopy.110) Lactic acidemia is present
not only in individuals undergoing high MET
exercise, but also in the majority of patients with
Y. KAGAWA [Vol. 86, 686mitochondrial disorders, including impaired HFo, and
cells isolated from such patients, similarly to ;0 cells,
require glucose medium (Fig. 8).22),87) Mitochondrial
disorders can be due to defects in nDNA directly
aﬀecting the assembly or function of HFoF1 and
respiratory chain, defects in mtDNA aﬀecting HFo
and the respiratory chain or nDNA inﬂuencing
mtDNA structure and viability.21),87)
The regulatory mechanism of HFoF1 including
four independent inhibitory sites111) are more com-
plex than those of TFoF1.7),108) AMP-activated
protein kinase (AMPK) activates both oxphos and
glycolysis, functioning as a ‘fuel gauge’ to monitor
AMP/ATP ratio (Fig. 10, left).112) ATP-sensitive
K+ channels both in the plasma membrane and in
mitochondria also monitors ATP levels to regulate
cellular activities.87),113) Increases in ATP concen-
tration close the K+ channel, and the resulting
depolarization opens L-type Ca2+ channels (Fig. 10,
bottom). Increased intracellular Ca2+ activates many
metabolic processes and proteins for mitochondrial
dynamics and secretion. For example, in the --cells of
mitochondrial myopathy, ATP-sensitive K+ channels
are not closed and defective Ca2+-dependent insulin
secretion results in mitochondrial diabetes.87) Mito-
chondrial ATP-sensitive K+ channels regulate energy
transfer through their regulation of intermembrane
space volume and are accordingly essential for the
inotropic response during periods of high METs.113)
Although the target residues in HFoF1 and their
signal routes have not yet been determined, mito-
chondrial ATP-sensitive K+ channels are closely
related to kinases including protein kinase CC.113) In
fact, detailed proteomics have revealed, for example,
phosphorylation of ,S76, -T213, -S529, .Y44 or
.Y52, and acetylation of ,K132, -K133, .K79 in
mammalian FoF1.91) The monomeric form of HFoF1
contains a phosphorylated . (.Y52) that is not
present in the dimeric form.91)
In contrast to bacteria, ATP synthesis by
HFoF1 requires exchange of Pi + ADP and ATP
between cytosol and mitochondria by PIC and ANC,
which are organized as the ATP synthasome
(Fig. 2).31) VDAC52) forming a complex with ANC
also plays an important role in cytoplasma-mitocon-
drial communication.103) As mammalian cells are
about 1000 times as large as bacteria, and a
mitochondrion is as large as a bacterium, mitochon-
drial dynamics are essential to distribute synthesized
ATP (Fig. 10, upper left).114) The concept of
mitochondrial dynamics includes the movement of
mitochondria along the cytoskeleton, the regulation
of mitochondrial morphology and distribution, and
connectivity mediated by tethering and fusion/
ﬁssion events.114) The relevance of these events in
HFoF1 activity has been unraveled after the identi-
ﬁcation of mitofusin87) and OPA1.98) Subjects with
diabetes showed reduced expression (by 26%) of
mitofusin 2 and a 39% reduction in the ,-subunit of
FoF1.115) Chronic exercise led to increases in VDAC,
and the ,-subunit of FoF1 in muscle from control
subjects and from those with diabetes.115) Acute
exercise caused a 4-fold increase in PGC-1, expres-
sion in muscle from control subjects, but not in those
with diabetes.115)
10.1. Inhibition of HFoF1 activity and dis-
eases related to bioenergetics. In the energy
metabolism of whole human body,114),116) if "7H+ is
too low, ATP production by HFoF1 cannot meet
demand (mitochondrial diseases),22),87) and if it is too
high, reactive oxygen species (ROS) are pro-
duced.23),89),116) Oxphos is linked to disease through
a lack of energy, excess ROS production, or a
combination of both,89),116) and diseases caused by
mitochondrial dysfunction include diabetes, cancer,
neurodegenerative disorders and ischemia-reperfu-
sion injury.23),89),116)
Because of its complex structure, HFoF1 is
inhibited by over 250 natural and synthetic inhib-
itors.117) In the absence of torque-driving energy,
HFoF1 switches from an ATP synthase to an ATP
hydrolase, and this occurs during myocardial ische-
mia. The degree of ATP ineﬃciently hydrolyzed
during ischemia may be as high as 50–90%.118) At
the start of FoF1 study, oligomycin was shown to
inhibit Fo,3),39)–42) and this portion of FoF1 was
therefore designated “oligomycin sensitivity confer-
ring factor”. Oligomycin cannot be used to treat
myocardial ischemia, as it would reduce ATP
synthesis in normal tissue.3) Only when cellular pH
is decreased below 6.8 under ischemia, IF1
78) inhibits
ATPase at the ,- interface of HF1.78) The restora-
tion of "7H+ favoring ATP synthesis displaces
IF1 from the ,- interface. However, IF1 does not
completely block hydrolase activity. BMS-199264
selectively inhibits ATPase activity during ischemia
while having no eﬀect on ATP synthesis, and
enhances the recovery of contractile function follow-
ing reperfusion.118) IF1, ectopic HFoF1 and the
opener of mitochondrial ATP-sensitive K+ chan-
nel113) protect cardiomyocytes from ischemic/reper-
fusion damage.
As HFoF1 supplies most ATP needed for human
activity, further study will provide useful insight for
ATP synthase: from single molecule to human bioenergetics No. 7] 687emergency medicine,118) mitochondrial cardiomy-
opathy22),87) and obesity-related chronic dis-
eases.23),115),116)
Conclusions
The excellent work to date on ATP synthases
(FoF1) has been reviewed based on data obtained in
studies on TFoF1 and HFoF1. The chemiosmotic
theory1) was ﬁrmly established by "7H+-driven ATP
synthesis in TFoF1 liposomes (Figs. 1 and 3),7),46) and
the rotational theory4) was established by crucial
observations of .-rotation10),11),17) and ATP synthesis
on externally added torque to rotate . in TF1
(Fig. 1).64) TF1 is the only F1 suﬃciently stable to
be consistently analyzed by reconstitution, crystal-
lography, mutagenesis, and nanotechnology for
torque-driven ATP synthesis.7) Crystallographic
analysis using BF1 (Figs. 2 and 5)9),25) and TF1
(Figs. 4–6),71),74) site-directed mutagenesis using
EFoF1
18),65) and TFoF1 (Figs. 5 and 6),12),20),63) and
dynamic nanotechnology79) have contributed to
elucidating elastic7),74) and loose61) energy coupling.
Based on the fundamental mechanism of ATP
synthesis in TFoF1,7),108) and functional complemen-
tation of YF1-deleted yeast with BF1 genes,8) human
bioenergetics was developed by research on HFoF1
using plasmids,21),28),86),97) transgenic mice
(Fig. 7),23),90),100) cytoplasts (Fig. 8)33),87) and omics
(Fig. 9).21),84),86),87) HFoF1 diﬀered from TFoF1 in
complex structure (Fig. 2), mitochondrial genetics
(Fig. 8),87) organ speciﬁcity (Fig. 7)90) and intricate
biogenesis (Fig. 9).86) The complex regulation of
HFoF1 has been shown to be essential for daily
human activity that is triggered by the brain
(Fig. 10), thus human bioenergetics is also applicable
to emergency medicine113),118) and obesity/diabe-
tes23),116) and mitochondrial diseases.87),97)
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